PDS Biotechnology files S-3 registration
- Filed S-3 on 2026-10-14
- Resale of 110,001,540 shares by Selling Stockholders
- Private placement in September 2026 raised $11.3M
Every EDGAR filing for PDS Biotechnology Corp (PDSB), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Ownership stake disclosure by Nant Capital, LLC
Nant Capital, LLC, filed by
Patrick Soon-Shiong, new insider at PDSB
Patrick Soon-shiong, reporting · Nant Capital, LLC, reporting
Janetta Trochimiuk, new insider at PDSB
Janetta Trochimiuk, reporting
Kamil Ali-Jackson, insider filing for PDSB
Kamil Ali-Jackson, reporting